BIEI Premier Biomedical Inc

USD 0.00 0.00 0
Icon

Premier Biomedical Inc (BIEI) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.0012

0.00 (0.00)%

USD 1.60M

0.73M

N/A

N/A

Icon

BIEI

Premier Biomedical Inc (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.60M

N/A

USD 0.00

Premier Biomedical Inc (BIEI) Stock Forecast

N/A

Based on the Premier Biomedical Inc stock forecast from 0 analysts, the average analyst target price for Premier Biomedical Inc is not available over the next 12 months. Premier Biomedical Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Premier Biomedical Inc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Premier Biomedical Inc’s stock price was USD 0.0012. Premier Biomedical Inc’s stock price has changed by +33.33% over the past week, +20.00% over the past month and -14.29% over the last year.

No recent analyst target price found for Premier Biomedical Inc
No recent average analyst rating found for Premier Biomedical Inc

Company Overview Premier Biomedical Inc

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on appli...Read More

PO Box 25, Jackson Center, PA, United States, 16133

0

December

USD

USA

Adjusted Closing Price for Premier Biomedical Inc (BIEI)

Loading...

Unadjusted Closing Price for Premier Biomedical Inc (BIEI)

Loading...

Share Trading Volume for Premier Biomedical Inc Shares

Loading...

Compare Performance of Premier Biomedical Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIEI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Premier Biomedical Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MKGAF
MERCK Kommanditgesellschaft au.. 0.00 (0.00%) USD76.84B 24.08 14.94

ETFs Containing BIEI

Symbol Name BIEI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Premier Biomedical Inc (BIEI) Stock

Stock Target Advisor's fundamental analysis for Premier Biomedical Inc's stock is Neutral.

Unfortunately we do not have enough data on BIEI's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIEI's stock to indicate what its average analyst target is.

BIEI stock's Price/Earning ratio is 0.10. Our analysis grades BIEI stock's Price / Earning ratio at A-. This means that BIEI stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this BIEI may be undervalued for its sector.

The last closing price of BIEI's stock was USD 0.00.

The most recent market capitalization for BIEI is USD 1.60M.

Unfortunately we do not have enough analyst data on BIEI's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Premier Biomedical Inc's stock.

As per our most recent records Premier Biomedical Inc has 0 Employees.

Premier Biomedical Inc's registered address is PO Box 25, Jackson Center, PA, United States, 16133. You can get more information about it from Premier Biomedical Inc's website at https://www.premierbiomedical.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...